Evidence map›Paper›PMID 27892500›Full record

ArticleScientific reports2016

Four translation initiation pathways employed by the leaderless mRNA in eukaryotes.

Kseniya A Akulich, Dmitry E Andreev, Ilya M Terenin, Victoria V Smirnova, Aleksandra S Anisimova, Desislava S Makeeva, Valentina I Arkhipova, Elena A Stolboushkina, Maria B Garber, Maria M Prokofjeva and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Mechanism of read-through enhancement by aminoglycosides and mefloquine.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Circadian Control of Protein Synthesis.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. How Dedicated Ribosomes Translate a Leaderless mRNA.Journal of molecular biology · 2024
    Article
  11. Review
  12. Structural insight into translation initiation of thebioRxiv : the preprint server for biology · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. High-risk human papillomavirus-18 uses an mRNA sequence to synthesize oncoprotein E6 in tumors.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Kseniya A AkulichEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
Dmitry E AndreevBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Ilya M TereninEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
Victoria V SmirnovaSchool of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, 119234, Russia.
Aleksandra S AnisimovaSchool of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, 119234, Russia.
Desislava S MakeevaSchool of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, 119234, Russia.
Valentina I ArkhipovaInstitute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region, 142290, Russia.
Elena A StolboushkinaInstitute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region, 142290, Russia.
Maria B GarberInstitute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region, 142290, Russia.
Maria M ProkofjevaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
Pavel V SpirinEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
Vladimir S PrassolovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
Ivan N ShatskyBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Sergey E DmitrievEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
Lomonosov Moscow State University · RUEngelhardt Institute of Molecular Biology · RUInstitute of Protein Research · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

mRNAs lacking 5' untranslated regions (leaderless mRNAs) are molecular relics of an ancient translation initiation pathway. Nevertheless, they still represent a significant portion of transcriptome in some taxons, including a number of eukaryotic species. In bacteria and archaea, the leaderless mRNAs can bind non-dissociated 70 S ribosomes and initiate translation without protein initiation factors involved. Here we use the Fleeting mRNA Transfection technique (FLERT) to show that translation of a leaderless reporter mRNA is resistant to conditions when eIF2 and eIF4F, two key eukaryotic translation initiation factors, are inactivated in mammalian cells. We report an unconventional translation initiation pathway utilized by the leaderless mRNA in vitro, in addition to the previously described 80S-, eIF2-, or eIF2D-mediated modes. This mechanism is a bacterial-like eIF5B/IF2-assisted initiation that has only been reported for hepatitis C virus-like internal ribosome entry sites (IRESs). Therefore, the leaderless mRNA is able to take any of four different translation initiation pathways in eukaryotes.

Indexed as

Cell-Free SystemEukaryotic CellsEukaryotic Initiation Factor-2Eukaryotic Initiation FactorsHEK293 CellsHepatitis CHumansInternal Ribosome Entry SitesMultiprotein ComplexesPeptide Chain Initiation, TranslationalProtein BiosynthesisRNA, MessengerSaccharomyces cerevisiaeTransfectionEukaryotic Initiation Factor-2eukaryotic initiation factor-5BEukaryotic Initiation FactorsInternal Ribosome Entry SitesMultiprotein ComplexesRNA, Messenger

Identifiers

PMID27892500
PMCPMC5124965
OpenAlexW2557976574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.